ACI Formulations (DHA:ACIFORMULA) ROIC %: 5.83% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ACIFORMULA ACI Formulations PLC DHA:ACIFORMULA
88 GF Score
Price BDT172.00
GF Value BDT149.48
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is ACI Formulations ROIC %?

ACI Formulations DHA:ACIFORMULA +1.42% 88 ROIC % is 5.83% as of Mar. 2026. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 88/100 and a GF Value™ of BDT149.48 (Modestly Overvalued). The stock has 8 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. ACI Formulations's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was 5.83%.

As of today (2026-07-27), ACI Formulations's WACC % is 8.58%. ACI Formulations's ROIC % is 6.15% (calculated using TTM income statement data). ACI Formulations earns returns that do not match up to its cost of capital. It will destroy value as it grows.


ACI Formulations  (DHA:ACIFORMULA) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, ACI Formulations's WACC % is 8.58%. ACI Formulations's ROIC % is 6.15% (calculated using TTM income statement data). ACI Formulations earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


ACI Formulations ROIC % Related Terms


ACI Formulations ROIC % Historical Data

* Premium members only.

The historical data trend for ACI Formulations's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACI Formulations ROIC % Chart

ACI Formulations Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.15 6.45 6.39 7.06 7.72

ACI Formulations Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.24 0.32 6.14 12.07 5.83

DHA:ACIFORMULA vs CTVA, CF, MOS: ROIC % Comparison

For the Agricultural Inputs subindustry, ACI Formulations's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACI Formulations ROIC % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, ACI Formulations's ROIC % distribution charts can be found below:

* The bar in red indicates where ACI Formulations's ROIC % falls into.


DHA:ACIFORMULA
88GF Score
ACI Formulations PLC DHA:ACIFORMULA
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACI Formulations ROIC % Calculation

ACI Formulations's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Jun. 2025 is calculated as:

ROIC % (A: Jun. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jun. 2024 ) + Invested Capital (A: Jun. 2025 ))/ count )
=724.167 * ( 1 - 24.41% )/( (6620.966 + 7567.758)/ 2 )
=547.3978353/7094.362
=7.72 %

where

Invested Capital(A: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7559.152 - 731.504 - ( 206.682 - max(0, 4024.921 - 4928.625+206.682))
=6620.966

Invested Capital(A: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8584.935 - 772.689 - ( 244.488 - max(0, 4718.251 - 5832.716+244.488))
=7567.758

ACI Formulations's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=579.516 * ( 1 - 18.51% )/( (7887.958 + 8317.939)/ 2 )
=472.2475884/8102.9485
=5.83 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9272.223 - 1031.641 - ( 352.624 - max(0, 5223.623 - 6474.279+352.624))
=7887.958

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9361.878 - 1000.22 - ( 43.719 - max(0, 5237.097 - 6476.497+43.719))
=8317.939

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 5.83% mean?
ACI Formulations (DHA:ACIFORMULA) has a ROIC % of 5.83% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on ACI Formulations and its competitors.
Is ACI Formulations' ROIC % too high?
ACI Formulations' current ROIC % is 5.83%. The Agriculture industry median ROIC % is 5.47. ACI Formulations' value of 5.83% is 6.6% above this industry median. Overall, ACI Formulations has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' ROIC % compare to CTVA and CF?
ACI Formulations' ROIC % of 5.83% can be compared against companies in the Agriculture industry. The industry median ROIC % is 5.47. ACI Formulations' value of 5.83% is 6.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for an Agriculture company?
The median ROIC % among Agriculture companies is 5.47, based on 257 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ACI Formulations's current ROIC % of 5.83% is 6.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on ACI Formulations and its competitors. For the Agriculture industry, the median ROIC % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ACI Formulations's current ROIC % is 5.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Modestly Overvalued. The stock's GF Value™ is BDT149.48, compared to a current price of BDT172.00 — trading 15.1% above its estimated fair value. The current ROIC % is 5.83% and 6.6% above the Agriculture industry median of 5.47. ACI Formulations' overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current ROIC % is 5.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?

Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued. The current stock price of BDT172.00 is trading 15.1% above its estimated GF Value™ of BDT149.48. GuruFocus considers ACI Formulations to be Modestly Overvalued.

Key valuation signals for DHA:ACIFORMULA:

  • ROIC %: 5.83%
  • GF Value™: BDT149.48 vs. price of BDT172.00 (15.1% above fair value)
  • GF Score™: 88/100 with 8 warning signs
  • Industry Position: 6.6% above the Agriculture median

No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ACI Formulations Business Description

Address ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
88GF Score

Get the complete analysis for DHA:ACIFORMULA

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT172.00
Price
BDT149.48
GF Value